Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 766 | 69 | 689 |
| Samples | 277 | 39 | 234 |
| Peptides | 192 | 32 | 158 |
Function
COQ6 · Coenzyme Q6, monooxygenase
The protein encoded by this gene belongs to the ubiH/COQ6 family. It is an evolutionarily conserved monooxygenase required for the biosynthesis of coenzyme Q10 (or ubiquinone), which is an essential component of the mitochondrial electron transport chain, and one of the most potent lipophilic antioxidants implicated in the protection of cell damage by reactive oxygen species. Knockdown of this gene in mouse and zebrafish results in decreased growth due to increased apoptosis. Mutations in this gene are associated with autosomal recessive coenzyme Q10 deficiency-6 (COQ10D6), which manifests as nephrotic syndrome with sensorineural deafness. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jun 2012].
Isoforms & Proteins
4 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
| Transcript | UniProt | Mutations | Peptides |
|---|---|---|---|
| ENST00000334571 | Q9Y2Z9 | 259 | 145 |
| ENST00000394026 | Q9Y2Z9-3 | 232 | 131 |
| ENST00000629426 | A0A0D9SFJ1* | 214 | 114 |
| ENST00000554920 | G3V434* | 61 | 51 |
Gene Properties
Recurrent Mutations
All 145 amino-acid changes on canonical ENST00000334571 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in COQ6 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in COQ6 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| T-Cell Non-Hodgkins Lymphoma | 1/26 4% | 0/0 0% |
| Hodgkins Lymphoma | 2/16 12% | 2/122 2% |
| T-Lymphoblastic Leukemia | 1/40 2% | 0/0 0% |
| Esophageal Squamous Cell Carcinoma | 1/51 2% | 59/2550 2% |
| Endometrial Carcinoma | 3/42 7% | 12/612 2% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 2/133 2% |
| Bladder Carcinoma | 1/58 2% | 13/956 1% |
| Cervical Carcinoma | 2/35 6% | 3/422 1% |
| Colorectal Carcinoma | 7/143 5% | 30/3239 1% |
| Glioblastoma | 1/98 1% | 0/0 0% |
| Burkitts Lymphoma | 2/32 6% | 0/196 0% |
| Other Sarcomas | 0/69 0% | 6/699 1% |
| Non-Cancerous | 1/104 1% | 5/830 1% |
| Melanoma | 2/210 1% | 11/1899 1% |
| Other Solid Cancers | 1/94 1% | 9/1515 1% |
| Biliary Tract Carcinoma | 1/54 2% | 5/950 1% |
| Hepatocellular Carcinoma | 2/46 4% | 10/2210 0% |
| Gastric Carcinoma | 2/74 3% | 8/1809 0% |
| Germ Cell Tumour | 0/25 0% | 1/169 1% |
| Esophageal Carcinoma | 0/23 0% | 4/769 1% |
| Pancreatic Carcinoma | 0/89 0% | 8/1611 0% |
| Non-Small Cell Lung Carcinoma | 1/304 0% | 7/1390 0% |
| Glioma | 0/52 0% | 10/2127 0% |
| Squamous Cell Lung Carcinoma | 3/57 5% | 1/810 0% |
| Meningioma | 0/3 0% | 1/252 0% |
| Breast Carcinoma | 2/144 1% | 11/3264 0% |
| Head and Neck Carcinoma | 0/85 0% | 5/1574 0% |
| Neuroendocrine Tumour | 1/154 1% | 1/577 0% |
| Ovarian Carcinoma | 1/109 1% | 2/998 0% |
| Kidney Carcinoma | 0/85 0% | 4/1862 0% |
Mutation Distribution
Where COQ6 is mutated · all tissues, split by cell line vs tissue
How many mutations in COQ6 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 54 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 766 mutations in COQ6
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|